Zhao Yueshan, Li Meixi, Zhang Juan, Wang Chao, Zhao Mengyao, Yang Qishuo, Wang Tianjun, Lv Peiyuan
Department of Neurology, Hebei Medical University, Shijiazhuang, China.
Department of Neurology, Hebei General Hospital, Shijiazhuang, China.
Front Aging Neurosci. 2025 Jun 18;17:1588488. doi: 10.3389/fnagi.2025.1588488. eCollection 2025.
Monocyte-to-high-density lipoprotein ratio (MHR), as a novel biomarker, has shown potential in predicting the onset and progression of various diseases. However, the relationship between MHR and cerebral small vessel disease (CSVD) as well as cognitive impairment (CI), which are inflammation-related conditions remains unclear. This research explores the relationship between MHR and total CSVD burden as well as CI.
This retrospective analysis included 212 eligible patients. On the basis of Mini-Mental State Examination (MMSE) scores, patients were classified into CI and no CI groups. Total CSVD burden was assessed using a composite score incorporating four MRI-based imaging markers. Participants were further stratified into mild and severe CSVD burden groups. MHR was determined by dividing the blood monocyte count by the high-density lipoprotein (HDL) concentration. Statistical analyses, including logistic regression, trend tests, restricted cubic spline modeling, and mediation analysis, were conducted using SPSS 26.0 and R software to explore the associations of MHR with CI, and CSVD burden.
Non-parametric analysis revealed that patients with CI and those with severe CSVD burden exhibited significantly higher MHR levels ( < 0.05) compared to their respective counterparts. Multivariable logistic regression identified elevated MHR (OR = 1.462, 95%CI: 1.057-2.022, = 0.022) and severe CSVD burden (OR = 2.456, 95%CI: 1.306-4.617, = 0.005) as significant risk factors for CI. Additionally, higher MHR levels were independently associated with severe CSVD burden (OR = 1.596, 95%CI: 1.092-2.334, = 0.016). Compared to the lowest MHR tertile, the highest tertile exhibited a remarkably higher risk of CI (OR = 3.743, 95%CI: 1.557-8.995; = 0.010) and severe CSVD burden (OR = 2.594, 95%CI: 1.086-6.195; = 0.019). Restricted cubic spline analysis confirmed a non-linear association between MHR and both CI and severe CSVD burden. Mediation analysis further demonstrated that CSVD burden significantly mediated the relationship between MHR and CI.
Elevated MHR is related to increased CSVD burden and CI. The mediating roles of severe CSVD burden indicates that a high MHR level may contribute to the progression of CSVD, thereby elevating the risk of CI.
单核细胞与高密度脂蛋白比值(MHR)作为一种新型生物标志物,在预测各种疾病的发生和发展方面已显示出潜力。然而,MHR与脑小血管疾病(CSVD)以及认知障碍(CI)(均为炎症相关病症)之间的关系仍不清楚。本研究探讨MHR与总CSVD负担以及CI之间的关系。
这项回顾性分析纳入了212例符合条件的患者。根据简易精神状态检查表(MMSE)评分,将患者分为CI组和非CI组。使用包含四个基于MRI的成像标志物的综合评分评估总CSVD负担。参与者进一步分为轻度和重度CSVD负担组。MHR通过将血液单核细胞计数除以高密度脂蛋白(HDL)浓度来确定。使用SPSS 26.0和R软件进行统计分析,包括逻辑回归、趋势检验、受限立方样条建模和中介分析,以探讨MHR与CI以及CSVD负担之间的关联。
非参数分析显示,与各自的对照组相比,CI患者和重度CSVD负担患者的MHR水平显著更高(<0.05)。多变量逻辑回归确定升高的MHR(OR = 1.462,95%CI:1.057 - 2.022, = 0.022)和重度CSVD负担(OR = 2.456,95%CI:1.306 - 4.617, = 0.005)是CI的显著危险因素。此外,较高的MHR水平与重度CSVD负担独立相关(OR = 1.59